SPACS: How should retail investors view the opportunity? January 26, 2022

SPACS: How should retail investors view the opportunity?

Three special purpose acquisition companies (SPACs) will be on the SGX.

The IPO offers are an attractive free lunch for investors. SPAC shares are 100% redeemable at S$5 offer price with free warrants thrown in with the shares. The public or retail offer is only 1.5 – 3.3% of the total issued shares.

We are cautious on SPACs post-IPO until valuations and ownership structures of the target companies are determined.

SPACS, or special purpose acquisition companies, is one of the terms that has now become part of the investor vocabulary in Singapore.

And with Vertex Technology Acquisition Corporation (VTAC), a SPAC established by Vertex Venture Holdings (Vertex Holdings), starting trading on the Singapore Exchange (SGX) on Jan 20, 2022, after being listed, interest in SPACS in Singapore is bound to grow exponentially.

Vertex is just the first of the SPACS to list on the SGX, after the Singapore Exchange in September allowed the listing of this type of initial public offering.

The other SPACs to list on the SGX in the near future are Pegasus Asia, or PA, and Novo Tellus Alpha Acquisition, NTAA, (pending).

SPACs, which offer an alternative to traditional IPOs, have been around in various forms for many decades. But it is only during the past two years that they have taken off in the United States, according to Max H. Bazerman and Paresh Patel in an article on SPACS in the Harvard Business Review.1

In 2019, 59 were created, with $13 billion invested; and in 2020, 247 were created, with $80 billion invested. In the first quarter alone of 2021, 295 were created, with $96 billion invested.

In 2020, the Harvard Business Review article said, SPACs accounted for more than 50% of new publicly listed US companies.

So, who are the main players in a SPAC? There are three main players in a SPAC – sponsors, investors and targets.

Who are sponsors? Sponsors initiate the SPAC process by investing risk capital in the form of non-refundable payments to bankers, lawyers, and accountants to cover operating expenses.

But if the sponsors fail to create a combination within the specified time frame, the SPAC must be dissolved and all funds returned to the original investors.

Then there are investors. The vast majority of investments in SPACs to date have come from institutional investors. And investors receive two classes of securities: shares and warrants that allow them to buy shares in the future at a specified price.

As for targets, most SPAC targets are start-up firms that have been through the venture capital process.

So, how should retail investors look at SPACS? According to Paul Chew, the head of research at Phillip Securities Research, a member of PhillipCapital Group, SPACs are “a free lunch for the few”.2

And his reasons for this:

  • Non-IPO investors are at a disadvantage. IPO investors in SPACs are essentially buying zero coupon capital-guaranteed bonds with free warrants (or convertible bonds). Put in simple terms, they can get back all their IPO subscription money (i.e. S$5 per unit) and yet enjoy free warrants. The opportunity cost for this is theoretically interest income foregone on a 2-year fixed deposit. Investors buying into the SPACs post-IPOs will be immediately disadvantaged even if they purchase at the initial issue price of S$5. The free warrants lower the cost for IPO investors.
  • Wait for the acquisition: We would prefer to wait until details of the target company are disclosed before deciding on investing in a SPAC. Investors must monitor both the valuations and shareholding structures. Valuations for the target company may be priced to perfection, or at best fairly valued. The target company will likely be issued shares in the SPAC in exchange for the acquisition. This may create a large share overhang if there is an insufficient lock-up period.

Comparison between the 3 SPACs to trade on SGX

  • VTAC’s structure stands out. Among the three SPACs, the VTAC structure stands out:
    i. Larger in size. VTAC has raised a larger cash sum of S$200mn. The other two SPACs are S$150mn each. A larger cash hoard should enable the SPAC to acquire a much larger and hopefully more attractive technology target company since scale is a competitive advantage.
    ii. Fewer warrants. VTAC units come with a 0.3 warrants each. The remaining 0.2 warrants are issued to shareholders that vote for the acquisition. The other two SPACs provide 0.5 warrant each, a much larger “free ride”.
    iii. Time and price-based vesting of promote shares. 49% of the sponsor promote shares can be exercised only 12 months after the acquisition. The remaining 51% of the promote shares vest only (or can be disposed of) at S$6 (17%*), $7 (17%) and $8 (17%). Both SPACs time the vesting of promote shares. PA has lower price vesting at S$5.75 (25%) and S$6.50 (25%). NTAA has no price vesting.
    *refer to proportion of total promote shares

Salient points of the three SPACs

  • At the point of listing, the SPACs will issue units. Each unit is entitled to one share and 0.3 warrants (VTAC) or 0.5 warrants (PA/NTAA). The warrants are detachable and can be sold separately.
  • Sponsor promote (or founder) shares are the virtually free equity given to the sponsor as compensation for completing the acquisitions.
  • Investors can redeem the $5 per share for cash if the acquisition (or business combination) is completed or after 24 months. Ironically, they can vote for the acquisition and still redeem their shares.
  • At-risk capital is used to fund the operations, offering expenses and other costs of the SPACs. The capital is raised via private placement warrants to the sponsor. These warrants are each priced at S$0.50 (VTAC/NTAA) and S$0.2 (PA). It is not entirely clear how the warrants were priced, but the S$0.50 is a good reference price for trading.

In conclusion, we believe that the life of a SPAC can be broadly separated into two stages.

At the IPO stage, we view the SPAC as a capital guaranteed bond, 100% backed by cash. And the warrants are a freebie for IPO investors.

However, post-IPO, investors are buying blindfolded. This is because the target is unknown, the valuations are unknown and vendor’s shares are unknown. As a result of this, we believe that only a small premium is warranted.

Summary of the three SPACs:

SPACS: How should retail investors view the opportunity?

Source: PSR, Prospectus, Draft Prospectus, Excludes over-allotment


  • [1]
  • [2]
  • Disclaimer

    These commentaries are intended for general circulation. It does not have regard to the specific investment objectives, financial situation and particular needs of any person who may receive this document. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of any person acting based on this information. Opinions expressed in these commentaries are subject to change without notice. Investments are subject to investment risks including the possible loss of the principal amount invested. The value of the units and the income from them may fall as well as rise. Past performance figures as well as any projection or forecast used in these commentaries are not necessarily indicative of future or likely performance. Phillip Securities Pte Ltd (PSPL), its directors, connected persons or employees may from time to time have an interest in the financial instruments mentioned in these commentaries. Investors may wish to seek advice from a financial adviser before investing. In the event that investors choose not to seek advice from a financial adviser, they should consider whether the investment is suitable for them.

    The information contained in these commentaries has been obtained from public sources which PSPL has no reason to believe are unreliable and any analysis, forecasts, projections, expectations and opinions (collectively the “Research”) contained in these commentaries are based on such information and are expressions of belief only. PSPL has not verified this information and no representation or warranty, express or implied, is made that such information or Research is accurate, complete or verified or should be relied upon as such. Any such information or Research contained in these commentaries are subject to change, and PSPL shall not have any responsibility to maintain the information or Research made available or to supply any corrections, updates or releases in connection therewith. In no event will PSPL be liable for any special, indirect, incidental or consequential damages which may be incurred from the use of the information or Research made available, even if it has been advised of the possibility of such damages. The companies and their employees mentioned in these commentaries cannot be held liable for any errors, inaccuracies and/or omissions howsoever caused. Any opinion or advice herein is made on a general basis and is subject to change without notice. The information provided in these commentaries may contain optimistic statements regarding future events or future financial performance of countries, markets or companies. You must make your own financial assessment of the relevance, accuracy and adequacy of the information provided in these commentaries.

    Views and any strategies described in these commentaries may not be suitable for all investors. Opinions expressed herein may differ from the opinions expressed by other units of PSPL or its connected persons and associates. Any reference to or discussion of investment products or commodities in these commentaries is purely for illustrative purposes only and must not be construed as a recommendation, an offer or solicitation for the subscription, purchase or sale of the investment products or commodities mentioned.

Contact us to Open an Account

Need Assistance? Share your Details and we’ll get back to you


This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  


Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066